Metagenomi Therapeutics, Inc. (MGX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-11

Metagenomi Therapeutics, Inc. (MGX) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-11. 2 Form 8-K material event filings were reported by MGX in the last 90 days. InsiderAlpha tracks every MGX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Metagenomi Therapeutics, Inc. (MGX)

SEC CIK0001785279

90-Day SEC Filing Activity

Form 4 filings (90d)7
Form 8-K filings (90d)2
Latest Form 4 filing2026-06-11

Recent MGX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Wapnick PamelaChief Financial OfficerS — Open-market sale2.9K$1.30$4KSEC
Irish JianSee RemarksS — Open-market sale3.7K$1.30$5KSEC
Wein MatthewSee RemarksS — Open-market sale558$1.30$725SEC
Irish JianSee RemarksA — Grant or award46.0K$0.00—SEC
Wapnick PamelaChief Financial OfficerA — Grant or award24.0K$0.00—SEC
Wein MatthewSee RemarksA — Grant or award11.0K$0.00—SEC
Wein MatthewSee RemarksS — Open-market sale482$1.60$771SEC
Wapnick PamelaChief Financial OfficerS — Open-market sale1.6K$1.60$3KSEC
Irish JianChief Executive OfficerS — Open-market sale1.6K$1.60$3KSEC
Wapnick PamelaChief Financial OfficerS — Open-market sale1.6K$1.77$3KSEC
Irish JianChief Executive OfficerS — Open-market sale1.6K$1.77$3KSEC
Wein MatthewSee RemarksS — Open-market sale199$1.77$353SEC
Thomas Brian C.InsiderS — Open-market sale3.8K$1.77$7KSEC
Irish JianChief Executive OfficerG — Bona-fide gift228.5K$0.00—SEC
Irish JianChief Executive OfficerA — Grant or award211.0K$1.60$338KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Metagenomi Therapeutics, Inc. (MGX). Updated in real time as new filings are submitted to the SEC.

Most-Active MGX Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
BJERKHOLT ERIC1—
Reid Laurence1—
Dere Willard H1—
Wein Matthew1$725
Irish Jian1$5K

Recent MGX Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MGX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

MGX Insider Trading — FAQ

What is the latest insider trade for MGX?
Metagenomi Therapeutics, Inc. (MGX) had 7 insider filings in the last 90 days, with the most recent on 2026-06-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying MGX stock?
0 insider purchases of MGX were filed in the last 90 days.
How many insiders are selling MGX stock?
0 insider sales of MGX were filed in the last 90 days.
Where can I see MGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every MGX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live MGX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.